BIIB logo

BIIB
Biogen Inc

18,634
Mkt Cap
$34.3B
Volume
3.4M
52W High
$202.41
52W Low
$110.04
PE Ratio
22.85
BIIB Fundamentals
Price
$198.60
Prev Close
$185.36
Open
$187.01
50D MA
$177.52
Beta
0.63
Avg. Volume
1.56M
EPS (Annual)
$8.79
P/B
1.62
Rev/Employee
$1.27M
Loading...
Loading...
News
all
press releases
Twin Capital Management Inc. Sells 5,246 Shares of Biogen Inc. $BIIB
Twin Capital Management Inc. decreased its holdings in Biogen Inc. (NASDAQ:BIIB - Free Report) by 43.6% in the third quarter, according to the company in its most recent 13F filing with the...
MarketBeat·16h ago
News Placeholder
More News
News Placeholder
Penserra Capital Management LLC Has $706,000 Holdings in Biogen Inc. $BIIB
Penserra Capital Management LLC grew its holdings in shares of Biogen Inc. (NASDAQ:BIIB - Free Report) by 41,941.7% during the third quarter, according to its most recent 13F filing with the SEC. The...
MarketBeat·17h ago
News Placeholder
Stifel Nicolaus Increases Biogen (NASDAQ:BIIB) Price Target to $214.00
Stifel Nicolaus lifted their price objective on shares of Biogen from $202.00 to $214.00 and gave the company a "buy" rating in a research note on Friday...
MarketBeat·2d ago
News Placeholder
Why Biogen Stock Surged Almost 9% Higher on Friday
Key PointsThe biotech published its last set of financials for 2025...
Nasdaq News: Markets·2d ago
News Placeholder
Biogen (NASDAQ:BIIB) Posts Quarterly Earnings Results, Beats Estimates By $0.27 EPS
Biogen (NASDAQ:BIIB - Get Free Report) issued its earnings results on Friday. The biotechnology company reported $1.99 earnings per share for the quarter, beating the consensus estimate of $1.72 by...
MarketBeat·2d ago
News Placeholder
BIIB Beats on Q4 Earnings & Sales, Stock Gains on Upbeat '26 EPS View
Biogen tops Q4 earnings and sales estimates, and shares rise after the company issues an encouraging 2026 adjusted EPS outlook despite revenue pressure.
Zacks·2d ago
News Placeholder
Pre-Markets Open in Green to Close the Week
Pre-Markets Open in Green to Close the Week.
Zacks·2d ago
News Placeholder
Biogen Hits 52-Week High, Alzheimer's Drug Sales Jump
Biogen beat fourth-quarter earnings and revenue estimates as growth from Leqembi, Skyclarys, and Zurzuvae offset declining multiple sclerosis sales, while the company forecast higher 2026...
Benzinga·2d ago
News Placeholder
Pre-Markets Rebounding Ahead of Super Bowl Sunday
We're seeing is a slight uptick at this hour for companies like Draft Kings (DKNG) and FanDuel parent Flutter (FLUT).
Zacks·2d ago
News Placeholder
Biogen (NASDAQ:BIIB) Sets New 12-Month High Following Earnings Beat
Biogen (NASDAQ:BIIB) Sets New 1-Year High on Strong Earnings...
MarketBeat·2d ago
<
1
2
...
>

Latest BIIB News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.